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Résumé 
 
 
Objectif : Alors qu’un antécédent d’AMS est couramment utilisé pour fournir des conseils et 
recommander une prophylaxie médicamenteuse pour les expositions ultérieures à la haute altitude, la 
reproductibilité intra-individuelle de l'AMS au cours d'expositions répétées n'a jamais été examinée 
dans une étude prospective contrôlée. 
 
 
Méthodes : Chez 27 enfants et 29 adultes non acclimatés, nous avons évalué la présence et la sévérité 
de l’AMS durant les 48 premières heures après une montée rapide à 3450m, et ceci en deux occasions 
distantes de 9 à 12 mois.  
 
 
Résultats : 18 adultes (62 %) et 6 enfants (22 %) ont souffert d’AMS durant la première exposition et 
14 adultes (48 %) et 4 enfants (15 %) durant la seconde (P=0.01, adultes versus enfants). Mais surtout, 
la reproductibilité intra-individuelle de l'AMS était très différente (P < 0.001) entre les deux groupes ; 
en effet, aucun des 6 enfants ayant souffert d'AMS au cours de la première exposition n’en n’a souffert 
au cours de la seconde mais 4 enfants sans AMS lors de la première exposition ont été touchés lors de 
la seconde exposition. Contrairement à cela, 14 des 18 adultes qui ont souffert de l’AMS lors de la 
première exposition ont également présenté ce problème au cours de la seconde et aucun nouveau cas 
ne s’est développé dans ceux qui n'avaient pas souffert de cette affection lors de la première occasion.  
 
 
Conclusion : Si chez l’adulte, un antécédent d’AMS a une bonne valeur prédictive d’un nouvel 
épisode durant les expositions futures dans des conditions similaires, il n’en est pas de même chez 
l’enfant chez lequel il n’a pas de valeur prédictive. Un antécédent d'AMS ne devrait donc pas inciter 
les praticiens à déconseiller la réexposition ou à prescrire une prophylaxie médicamenteuse chez 
l’enfant.  
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Reproducibility of Acute Mountain Sickness in
Children and Adults: A Prospective Study
WHAT’S KNOWN ON THIS SUBJECT: Although a history of
previous acute mountain sickness is often used for providing
advice and recommending its prophylaxis during subsequent
exposure, the intraindividual reproducibility of acute mountain
sickness during repeated high-altitude exposure has never been
examined in a controlled study.
WHAT THIS STUDY ADDS: A history of acute mountain sickness
strongly predicts future illness in adults but not in children.
Advice to avoid re-exposure to high altitude or prescription of
prophylactic medications is not indicated in children.
abstract
OBJECTIVE: Although a history of previous acute mountain sickness
(AMS) is commonly used for providing advice and recommending its
prophylaxis during subsequent exposure, the intraindividual repro-
ducibility of AMS during repeated high-altitude exposure has never
been examined in a prospective controlled study.
METHODS: In 27 nonacclimatized children and 29 adults, AMS was as-
sessed during the ﬁrst 48 hours after rapid ascent to 3450 m on 2
consecutive occasions 9 to 12 months apart.
RESULTS: During the ﬁrst exposure, 18 adults (62%) and 6 children
(22%) suffered from AMS; during the second exposure, 14 adults (48%)
and 4 children (15%) suffered from this problem (adults versus chil-
dren, P .01). Most importantly, the intraindividual reproducibility of
AMSwas very different (P .001) between children and adults. None of
the 6 children having suffered from AMS during the ﬁrst exposure
suffered from AMS during the second exposure, but 4 children with no
AMS during the ﬁrst exposure did experience this problem during the
second exposure. In contrast, 14 of the 18 adults who suffered from
AMS on the ﬁrst occasion also presented with this problem during the
second exposure, and no new case developed in those who had not
experienced AMS on the ﬁrst occasion.
CONCLUSIONS: In adults, a history of AMS is highly predictable of the
disease on subsequent exposure, whereas in children it has no predic-
tive value. A history of AMS should not prompt practitioners to advise
against reexposure to high altitude or to prescribe drugs for its pro-
phylaxis in children. Pediatrics 2011;127:e000
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Travel to high-altitude destinations for
business and recreational purposes
has become increasingly popular, and
large numbers of persons are exposed
to high-altitude–related medical risks.
Among these risks, acute mountain
sickness (AMS) is by far the most fre-
quent problem occuring in more than
80% of tourists arriving by plane at
3740 m.1 AMS is a syndrome of nonspe-
ciﬁc symptoms, including headache
and 1 or more of the following: fatigue,
anorexia and nausea, dizziness, and
sleep disturbance, often developing
within hours after arriving at altitudes
2500 m.2 It affects otherwise healthy
persons and in most cases resolves
spontaneously, but in some cases it
progresses to life-threatening high-
altitude cerebral edema.2 A history of
AMS is often used for providing advice
about the risk of its reoccurrence and
deciding about the indication for its
pharmacologic prophylaxis during
subsequent high-altitude exposure; to
the best of our knowledge, however,
there is surprisingly little information
on the intraindividual reproducibility
of AMS during repeated high-altitude
exposure in adults,3,4 and no such in-
formation in children. In a prospective,
controlled study, we therefore as-
sessed the prevalence of AMS in non-
acclimatized children and adults with
no previous high-altitude experience
during the ﬁrst 48 hours after rapid
ascent by train to 3450 m on 2 consec-
utive occasions 9 to 12 months apart.
METHODS
Study Group
We studied 27 healthy Swiss children
(mean [SD] age: 12 [2] years; range:
8–16 years; 20 girls; height: 150 [14]
cm; weight: 43.0 [11.4] kg; BMI: 19.8
[2.6]) and 29 healthy Swiss adults
(mean [SD] age: 39 [8]; range: 26–63
years; 11 women; height: 175 [8] cm;
weight: 71.9 [11.7] kg; BMI: 23.5 [2.9]).
All participants had regular physical
activity and were living at altitudes
700m. None of the participants was
obese (BMI 30), had slept at high
altitude (1500 m) during the 3
months preceding the 2 studies,
none had ever spent a night at an
altitude2000 m, and none was tak-
ing any medication during the stud-
ies. The experimental protocol was
approved by the Institutional Review
Board on Human Investigation, and
all participants (including the chil-
dren as well as their parents) pro-
vided written informed consent.
The study took place on 2 consecutive
occasions 9 to 12 months apart. The
participants ascended with a 21⁄2-hour
train ride that took them from 568m to
the Jungfraujoch International High Al-
titude Research Station at 3450 m,
where they arrived in the early after-
noon. They then spent 2 days and 2
nights in small bedrooms at the re-
search station. During the stay, all par-
ticipants received the same diet, and
care was taken to assure adequate
ﬂuid intake (2 L/d). Adult partici-
pants refrained from alcohol con-
sumption at high altitude. Physical ac-
tivity was standardized. On the day of
arrival, the participants rested quietly
and visited the research station and
the adjacent installations. In the af-
ternoon of the second day, all partic-
ipants made an easy 2- to 21⁄2-hour
walk to the Mönchsjoch Hut located
at 3650 m. On the morning before de-
scent the participants remained
within the research station.
Evaluation for Acute Mountain
Sickness
The presence of AMS was assessed on
the evening of the day of arrival and
on the 2 following mornings (at 6, 18,
and 42 hours after arrival at high alti-
tude) with a French version of the
Lake Louise Scoring System, a self-
assessment questionnaire,5 under the
supervision of a trained examiner.
Brieﬂy, for each of the 5 items (head-
ache, gastrointestinal symptoms, fa-
tigue, dizziness, and sleep disturbance),
theparticipantsnotedascorebetween0
and 3, with 0 indicating the absence of
the symptom; 1, mild symptoms; 2, mod-
erate symptoms; and 3, severe, incapac-
itating symptoms. For children younger
than 12 years of age, a verbally adapted
version of the score was used (Lake Lou-
ise age-adjusted symptom score).6 Par-
ticipants were considered suffering
from AMS if they were experiencing
headache and scored 3 on the self-
assessment questionnaire (themaximal
score for thequestionnairewas15)onat
least 1 of the 3 assessments.5
Measurement of Arterial Oxygen
Saturation
Transcutaneous arterial saturation
and heart rate were measured at a ﬁn-
gertip with a pulse oximeter (OxiMax
N-595, Nellcor, Pleasanton, CA).
Statistical Analysis
Statistical analysis was performed by
using paired and unpaired Student’s t
tests for within- and between-group
comparisons of normally distributed
variables. The Fisher’s exact test was
used for between-group comparisons of
the prevalence and reproducibility of
AMS. Predictive values and conﬁdence
intervals (CIs) were calculated as previ-
ously described.7 Data are expressed as
mean (SD). A P value 0.05 was consid-
ered to indicate statistical signiﬁcance.
RESULTS
Arterial oxygen saturation at high alti-
tude was similar in children (90% [2%]
[95% CI: 86%–94%]) and adults (90%
[3%] [95%CI: 84%–93%]),whereasheart
rate, as expected, was more rapid (P
.001) in children (99 [12] beats per min-
ute [95% CI: 75–122 beats per minute])
than in adults (80 [9] beats per minute
[95% CI: 76–85 beats per minute]).
All subjects completed the Lake Louise
questionnaire during both exposures.
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The overall prevalence of AMS was sig-
niﬁcantly higher in adults than in chil-
dren. During the ﬁrst exposure, 18 of
the 29 adults (62%) and 6 of the 27
children (22%) suffered from AMS
(P  .003); during the second expo-
sure, 14 adults (48%) and 4 children
(15%) suffered from this problem (P
.01) (Fig 1). The intraindividual repro-
ducibility of AMS was markedly differ-
ent between children and adults (P 
.001; Fig 1). In children, a history of
AMS did not predict its recurrence, be-
cause none of the 6 children having
suffered from AMS during the ﬁrst expo-
sure suffered from AMS during the sec-
ond exposure. However, 4 children, who
had not suffered from AMS during the
ﬁrst exposure, experienced it during the
second exposure (positive predictive val-
ue: 0% [95% CI: 0%–48%]; negative pre-
dictive value: 81% [95%CI: 57%–94%]). In
contrast, AMS was very reproducible in
adults; 14 of the 18 adults who suffered
from AMS on the ﬁrst occasion also pre-
sentedwith this problem during the sec-
ond exposure, and no new cases devel-
oped in those adults who had not
suffered from AMS on the ﬁrst occasion
(positive predictive value: 78% [95% CI:
52–93%]; negative predictive value:
100% [95% CI: 68%–100%]). In children
and adults, the prevalence of AMS was
similar in both genders.
Among the participants who suffered
from AMS, the severity of the disease
was similar in children and adults dur-
ing both exposures; during the ﬁrst ex-
posure, the mean (SD) score was 3.8
(1.2) (95% CI: 3–6) in children and 4.6
(1.4) (95% CI: 3–8) in adults (P .24);
during the second exposure it was 4.3
(1.0) (95% CI: 3.0–5.0) and 4.4 (1.4)
(95% CI: 3.0–7.0), respectively (P 
.78). None of the subjects developed
clinical signs of high-altitude cerebral
or pulmonary edema.
Independent of whether AMSwas pres-
ent or not, headache and sleep distur-
bances weremore severe (P .001) in
adults than in children: mean head-
ache score was 0.86 (0.83) versus 0.30
(0.57) (95% CI: 0.0–2.1 vs 0.0–2.0) and
sleep disturbance score was 1.07
(0.83) versus 0.39 (0.68) (95% CI: 0.0–
2.1 vs 0.0–2.0), whereas the scores for
gastrointestinal symptoms, fatigue,
and dizziness were similar in the 2
groups. Moreover, headache was also
signiﬁcantly (P .006) more frequent
in adults (23 of 29) than in children (11
of 27), whereas the frequency of the
other 4 symptoms making up for AMS
was similar in children and adults.
DISCUSSION
AMS is a frequent problem in travelers
ascending to high-altitude locations.
Its occurrence during previous expo-
sure is commonly used for providing
advice and deciding about the indica-
tion for its prophylaxis during subse-
quent exposures, but there is little
information on its intraindividual re-
producibility.2 In this prospective con-
trolled study, we found that the intra-
individual reproducibility of AMS was
very different between children and
adults. Although nearly 80% of the
adults who had suffered from AMS
during the ﬁrst exposure also suffered
from this problem during the second
exposure, none of the children who
had suffered from AMS on the ﬁrst oc-
casion suffered from this problem
again. These ﬁndings indicate that AMS
history is useful for providing advice
and to guide the prescription of drugs
for its prophylaxis in adults but not in
children.
Our data indicate that, in adults, AMS
history not only allows to predict with
a high probability its recurrence dur-
ing subsequent exposure; it also al-
lows excluding its occurrence in those
who had not suffered from this prob-
lem, because none of the adults who
had not suffered from AMS during the
ﬁrst exposure suffered from this prob-
lem during the second exposure. In
contrast, in children not suffering
from AMS during the ﬁrst exposure did
not exclude its occurrence during sub-
sequent exposure, as demonstrated by
the 4 children whowere asymptomatic
during the ﬁrst exposure but suffered
from AMS during the second exposure.
The reason for this difference of the
intraindividual reproducibility of AMS
between children and adults is not
clear but could possibly involve vari-
ability in the self-perception of illness
in children.8
The present data also provide the ﬁrst
direct comparison of the prevalence of
AMS between children and adults un-
der strictly controlled conditions. The
markedly lower prevalence of AMS in
children than in adults was unex-
pected, because it has been suggested
that the incidence of AMS may be in-
versely related to age.9 This ﬁnding
FIGURE 1
Schematic representation of the presence or absence of AMS in 27 children and 29 adults during the
ﬁrst 48 hours after rapid ascent by train from 568 to 3450 m during 2 subsequent exposures 9 to 12
months apart. Each line represents a subject.
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does not seem to be related to a par-
ticularly high prevalence of AMS in
adults in the present study, because it
was similar or lower than the one re-
ported in previous studies.1,10 It was
also not related to an unexpectedly low
prevalence of AMS in children in the
present study, because the prevalence
of AMSwas similar to the one reported
in an earlier study at this altitude.11
In this controlled study, we were able
to control for several important con-
founding factors that may facilitate or
mimic AMS. Exercise represents a risk
factor for AMS, and more intense exer-
cise has been suggested to explain the
higher prevalence of AMS in young ver-
sus elderly mountaineers in an earlier
study.12 Here, we found that when exer-
cise is controlled, the AMS prevalence
was lower in children than in adults. In
adults, alcohol consumption may ag-
gravate or mimic AMS.13,14 This factor
did not come into play in the present
study, because adults refrained from
alcohol at high altitudes. A chamber
study suggested that obesity may rep-
resent a risk factor for AMS in adults.15
None of the subjects in our study was
obese.
CONCLUSIONS
Current guidelines suggest pharmaco-
logic prophylaxis for AMS in persons
rapidly ascending to high altitude,2 in
particular in the presence of a history
of previous AMS. The ﬁndings of the
present controlled prospective study
provide the scientiﬁc foundation for
this attitude in adults. In contrast, in
children, AMS history is not a useful
guide for prescribing or withholding
pharmacologic prophylaxis. Moreover,
the low prevalence, mild manifesta-
tion, and benign course of AMS in chil-
dren rapidly ascending to this altitude
at which major tourist destinations
are located worldwide suggest that
pharmacologic prophylaxis for AMS is
not needed, and the use of drugs can
be reserved for the treatment of symp-
toms, if they appear. Finally and most
importantly, in children, a history of a
previous AMS should also not prompt
practitioners to advise against reexpo-
sure to high altitudes.
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